Autolus Therapeutics plc - ADR
AUTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$641.41M
Close$
$-1.15
150.4% downside
Current Fair Value
150.4% downsideOvervalued by 150.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $641.41 Million |
|---|---|
| Enterprise Value | $553.50 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 2.02 |
| Outstanding Shares | 266,158,829 |
Return
| Return on Equity | -374.17% |
|---|---|
| Return on Assets | -56.77% |
| Return on Invested Capital | -55.56% |
Valuation & Multiples
| P/E Ratio | -2.27 |
|---|---|
| PEG | 12.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.72 |
| Enterprise Value to EBIT | -2.35 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 1.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$38.56 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$38.11 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 13.85% |
|---|---|
| Total Calls | 338,700▲ 369.11% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 50.51%▼ 1.81% |
|---|---|
| Total Invested | $184.35M▼ 33.42% |
| Investors Holding | 87▼ 5.00% |
ESG Score
No data